Recent IPOs saw their valuations collapse in 2022, but as public investors sit on the sidelines, buyout firms and corporations are hunting for bargains amid the IPO wreckage. For companies that have gone public via IPO or SPAC merger since 2015, more than 40 have received, agreed to, or completed buyout offers since the start of 2022.
Healthcare companies CinCor Pharma (CINC) and Oak Street Health and fintechs Duck Creek Technology and Paya are the latest names to grab headlines, all of which jumped last week on buyout news.
Last week, AstraZeneca agreed to acquire hypertension biotech CinCor for...
To read the rest of the article, sign up for a free trial of IPO Pro, the platform that gives you all of the IPO information you need, all in one place.
